Serratiopeptidase STADA® 10mg
Packaging: Blister of 10 tablets. Box of 10 blisters.
Composition: Each enteric-coated tablet contains:
Serratiopeptidase 10 mg
Excipients q.s 1 tablet
Inflammation after operation and traumatic injury, inflammatory edema and swelling in internal or external hemorrhoid.
Therapy for inflammation in the following diseases:
Otorhinolaryngology: sinusitis, otitis, acute or chronic otitis media, pharyngitis, post-antrostomy, gingivitis and alveolar abscess.
Gynaecology: engorgement of the breast.
Urology: cystitis, epididymitis.
Opthalmology: hemorrhage in eye, opaque of vitreous.
Antibiotic treatment should be concomitantly administered in case of evolutive infectious factor.
Inadequate expectoration of sputum in the following cases: bronchitis, pulmonary tuberculosis, bronchial asthma and after anesthesia.
Serratiopeptidase STADA® 10 mg is taken orally, swallowed whole not chewed.
The usual dose in adults is 1 tablet x three times daily after meals.
Hypersensitivity to serratiopeptidase or any ingredient of this drug.
Hypersensitive reactions: rash and redness may occur. If such reactions occur, the drug should be discontinued
Digestive troubles: diarrhoea, anorexia, gastric discomfort, nausea or vomiting may occur
Hematologic: rarely, bleeding tendency, e.g. epistaxis and bloody sputum may occur
Shelf - Life:
24 months from the date of manufacturing.